Based on the role of USP4 in stabilizing BRCA1, we infer that loss or aberrant expression of USP4 may play a role in non-familiar breast and ovarian cancer and could correlate with the altered BRCA1 level. This evidence concerns the gene BRCA1 and ovarian carcinoma.